Mediwound Enterprise Value over EBITDA from 2010 to 2024
| MDWD Stock | USD 15.76 0.01 0.06% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (6.08) | Current Value (6.39) | Quarterly Volatility 57.32286102 |
Check Mediwound financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mediwound main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 405.6 K or Selling General Administrative of 7.8 M, as well as many exotic indicators such as Price To Sales Ratio of 4.66, Dividend Yield of 0.0 or PTB Ratio of 2.76. Mediwound financial statements analysis is a perfect complement when working with Mediwound Valuation or Volatility modules.
Mediwound | Enterprise Value over EBITDA |
About Mediwound Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Mediwound income statement, its balance sheet, and the statement of cash flows. Mediwound investors use historical funamental indicators, such as Mediwound's Enterprise Value over EBITDA, to determine how well the company is positioned to perform in the future. Although Mediwound investors may use each financial statement separately, they are all related. The changes in Mediwound's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Mediwound's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Mediwound Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Mediwound. Please read more on our technical analysis and fundamental analysis pages.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel. Mediwound operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 77 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Mediwound in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Mediwound's short interest history, or implied volatility extrapolated from Mediwound options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Mediwound Correlation against competitors. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Mediwound Stock analysis
When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Mediwound's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.75) | Revenue Per Share 2.073 | Quarterly Revenue Growth (0.54) | Return On Assets (0.17) | Return On Equity (0.32) |
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.